Get started
Author

Hitt Sharma

Observed names: H. Sharma, H.J. Sharma, Hitt J Sharma, Hitt J. Sharma, Sharma, Hitt J
ORCID: 0000-0002-3321-5257
Observed ORCID: 0000-0002-3321-5257
OpenAlex ID: A5050890189
Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial
2023 · Hitt Sharma, Sameer Parekh, et al. · The Lancet Oncology · 52
VPM1002 as Prophylaxis Against Severe Respiratory Tract Infections Including Coronavirus Disease 2019 in the Elderly: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study
2022 · Alexandra M Blossey, Sina Brückner, et al. · Clinical Infectious Diseases · 37
PDF
Results of the phase I open label clinical trial SAKK 06/14 assessing safety of intravesical instillation of VPM1002BC, a recombinant mycobacterium Bacillus Calmette Guérin (BCG), in patients with non-muscle invasive bladder cancer and previous failure of conventional BCG therapy
2020 · Cyrill A. Rentsch, Piet Bosshard, et al. · OncoImmunology · 34
PDF
Seroprevalence of rubella and immunogenicity following rubella vaccination in adolescent girls in India
2011 · Hitt J Sharma, Vasant S Padbidri, et al. · The Journal of Infection in Developing Countries · 30
PDF
Immunogenicity and safety of an indigenously manufactured reconstituted pentavalent (DTwP-HBV+Hib) vaccine in comparison with a foreign competitor following primary and booster immunization in Indian children
2011 · Hitt J. Sharma, Sangita Yadav, et al. · Human Vaccines · 28
PDF
A phase III randomized, controlled study to assess the immunogenicity and tolerability of DTPw–HBV–Hib, a liquid pentavalent vaccine in Indian infants
2011 · Hitt Sharma, Sangita Yadav, et al. · Vaccine · 25
Sero-Surveillance to assess immunity to rubella and assessment of immunogenicity and safety of a single dose of rubella vaccine in school girls
2010 · Hitt Sharma, Sunil Chowdhari, et al. · Indian Journal of Community Medicine · 22
Antibody persistence of two pentavalent DTwP–HB–Hib vaccines to the age of 15–18 months, and response to the booster dose of quadrivalent DTwP–Hib vaccine
2012 · Hitt Sharma, Sangeeta Yadav, et al. · Vaccine · 20
Immunization coverage and immunity to diphtheria and tetanus among children in Hyderabad, India
2009 · Manoj V. Murhekar, Sailaja Bitragunta, et al. · Journal of Infection · 20
An immunogenicity, safety and post-marketing surveillance of a novel adsorbed human diploid cell rabies vaccine (Rabivax®) in Indian subjects
2008 · M.K. Sudarshan, S. Bhardwaj, et al. · Human Vaccines · 20
PDF
Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process
2011 · Hitt J. Sharma, Vishwanath D. Patil, et al. · Vaccine · 16
A prospective comparative study to assess the efficacy and tolerability of 2 different doses of intravesical bacillus Calmette-Guerin (BCG) in patients with non–muscle-invasive bladder cancer
2020 · Rajeev Sood, Hitt Sharma, et al. · Urologic Oncology Seminars and Original Investigations · 15
Multiplexed bead-based assay for the simultaneous quantification of human serum IgG antibodies to tetanus, diphtheria, pertussis toxin, filamentous hemagglutinin, and pertactin
2023 · Vishal Rathod, Laxmikant Kadam, et al. · Frontiers in Immunology · 14
No demonstrable association between the Leningrad-Zagreb mumps vaccine strain and aseptic meningitis in a large clinical trial in Egypt
2009 · H.J. Sharma, S. Aly Oun, et al. · Clinical Microbiology and Infection · 14
Safety and immunogenicity of single dose of tetanus–diphtheria (Td) vaccine among non/partially immune children against diphtheria and/or tetanus, Hyderabad, India, 2007
2010 · Sailaja Bitragunta, Manoj V. Murhekar, et al. · Vaccine · 12
Vaccines For Type 1 Diabetes: Prevention or Reversal?
2020 · Shivani Desai, Shubhangi Buchade, et al. · Current Diabetes Reviews · 8
A phase III randomized-controlled study of safety and immunogenicity of DTwP-HepB-IPV-Hib vaccine (HEXASIIL®) in infants
2024 · Hitt Sharma, Sameer Parekh, et al. · npj Vaccines · 7
PDF
A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16–24 months
2022 · Hitt Sharma, Sanjay Lalwani, et al. · Human Vaccines & Immunotherapeutics · 7
Safety and immunogenicity of an indigenously developedHaemophilus influenzaetype b conjugate vaccine through various phases of clinical trials
2009 · Hitt J. Sharma, Amrik S. Multani, et al. · Human Vaccines · 6
PDF
Sero-surveillance to assess rubella susceptibility and assessment of immunogenicity and reactogenicity of rubella vaccine in Indian girls aged 18-24 years
2014 · Deepak S Phalgune, Rajiv C Yervadekar, et al. · Human Vaccines & Immunotherapeutics · 5
PDF
Regulatory Practice in Pharmaceutical Industry
2014 · Hitt Sharma · Pharmaceutical Regulatory Affairs Open Access · 5
A phase III, randomized controlled study to assess the safety and immunogenicity of a semi-synthetic diphtheria, tetanus and whole-cell pertussis vaccine in Indian infants
2012 · Hitt Sharma, Vishwanath Patil, et al. · Vaccine · 5
A phase III randomized, controlled study to assess and compare the immunogenicity and tolerability of single and multi-dose vials of DTwP-Hib, a fully liquid quadravalent vaccine and their comparison with TETRAct-Hib vaccine in Indian infants aged 6–14 weeks
2011 · Hitt Sharma, Sangita Yadav, et al. · Vaccine · 5
Quantitative bead–based multiplex assay for simultaneous determination of IgG concentrations of pertussis toxin, filamentous hemagglutinin, pertactin, diphtheria, tetanus, Haemophilus influenzae b, and hepatitis B in human serum samples
2025 · Vishal Rathod, Sagar Katke, et al. · Frontiers in Immunology · 3
PDF
A phase-I, open label clinical trial to assess the safety & tolerability of qHPV vaccine manufactured by Serum Institute of India Pvt. Ltd. in adults
2023 · Hitt Sharma, K. Anil, et al. · Vaccine X · 3
Works count: 49
Citation count: 430
H-index: 14
I10-index: 15
Year
Topic
Type